TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9329413

Group type: EXPERIMENTAL
Intervention: Prednisone (1 mg/kg per day orally) for 5 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bronchodilator reversibility testing with albuterol
Number of subjects: 16
Study: 7633086

Group type: EXPERIMENTAL
Intervention: Damp dusting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-damp dusting
Number of subjects: 0
Study: 3130322

Group type: EXPERIMENTAL
Intervention: Comprehensive case management with additional funding for direct community services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive case management with expanded coverage of community services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 29362512

Group type: EXPERIMENTAL
Intervention: Aripiprazole (APZ) titrated to 15 mg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Aripiprazole (APZ)
Number of subjects: 94
Study: 26899003

Group type: EXPERIMENTAL
Intervention: Amniotic scaffold balloon after TCRA
Number of subjects: 57

Group type: COMPARATOR
Intervention: Foley's balloon after TCRA
Number of subjects: 57
Study: 26282845

Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT) with nutrition education
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 23626800

Group type: EXPERIMENTAL
Intervention: Smoking cessation (after 3 years)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Continuing smokers
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Lifetime smoking burden
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Current cigarettes/day
Number of subjects: 532
Study: 21181669

Group type: EXPERIMENTAL
Intervention: HPS (Human Patient Simulator)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CD-ROM
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control
Number of subjects: 92
Study: 18854693

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 0
Study: 17149401

Group type: EXPERIMENTAL
Intervention: Educational homecare program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 15259929

Group type: EXPERIMENTAL
Intervention: Peripheral Anterior Chamber Depth (PACD) measurement
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Central Anterior Chamber Depth (CACD) measurement
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Peripheral Anterior Chamber Depth (PACD) and Central Anterior Chamber Depth (CACD) measurements
Number of subjects: 490
Study: 10736981

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 30
Study: 9013228

Group type: EXPERIMENTAL
Intervention: Chlormadinone acetate (100 mg/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Flutamide (375 ng/day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: LH-RH analogue
Number of subjects: 14
Study: 1411081

Group type: EXPERIMENTAL
Intervention: Active electro-stimulator device
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 77
Study: 4008128

Group type: EXPERIMENTAL
Intervention: Low-dose marijuana cigarettes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose marijuana cigarettes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo marijuana cigarettes
Number of subjects: 0
Study: 30502284

Group type: EXPERIMENTAL
Intervention: Dynamic Visual Feedback (VBF)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Without feedback
Number of subjects: 19
Study: 29241617

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention led by female community health volunteers (FCHVs) with home visits every 4 months for lifestyle counselling and blood pressure monitoring.
Number of subjects: 1638

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1638
Study: 27028911

Group type: EXPERIMENTAL
Intervention: Doxycycline (12-week oral course)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Clarithromycin plus hydroxychloroquine (12-week oral course)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo (12-week course)
Number of subjects: 280
Study: 24295850

Group type: EXPERIMENTAL
Intervention: 10 day sequential therapy (SEQ)
Number of subjects: 357

Group type: COMPARATOR
Intervention: 10 day modified bismuth quadruple therapy (QUAD)
Number of subjects: 357
Study: 22281194

Group type: EXPERIMENTAL
Intervention: PA MDC group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IA + PA MDC group
Number of subjects: 100

Group type: COMPARATOR
Intervention: IA MDC group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 20131570

Group type: EXPERIMENTAL
Intervention: 20/50 blur level
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 20/100 blur level
Number of subjects: 124

Group type: COMPARATOR
Intervention: 20/20 blur level
Number of subjects: 124
Study: 18092206

Group type: EXPERIMENTAL
Intervention: Consanguineous populations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homozygote (‐alpha/‐alpha) children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homozygote (‐alpha/‐alpha) frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha(+)‐thalassemia allele frequency
Number of subjects: 0
Study: 15470212

Group type: EXPERIMENTAL
Intervention: Carotid-artery stenting with an emboli-protection device
Number of subjects: 334

Group type: COMPARATOR
Intervention: Endarterectomy
Number of subjects: 334
Study: 11450675

Group type: EXPERIMENTAL
Intervention: Single 200-mg dose of doxycycline
Number of subjects: 482

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 482
Study: 9549926

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phlebotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alpha-interferon and anagrelide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antithrombotic drugs (e.g., aspirin)
Number of subjects: 0
Study: 7798165

Group type: EXPERIMENTAL
Intervention: Manual plasma exchange (PE)
Number of subjects: 41
Study: 2903170

Group type: EXPERIMENTAL
Intervention: Sodium valproate (1600 mg/day) for 6 days
Number of subjects: 11
Study: 30096258

Group type: EXPERIMENTAL
Intervention: In vitro activation of naive CD4+ T cells
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Regulatory T cells (Tregs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Age-related effects
Number of subjects: 18
Study: 28768502

Group type: EXPERIMENTAL
Intervention: VolleyVeilig intervention (warm-up program with more than 50 distinct exercises)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Volleyball as usual (control group)
Number of subjects: 0
Study: 26372583

Group type: EXPERIMENTAL
Intervention: 40 minutes of additional outdoor activities added to each school day, with encouragement for parents to engage children in outdoor activities after school hours.
Number of subjects: 1903

Group type: COMPARATOR
Intervention: Usual pattern of activity (control group).
Number of subjects: 1903

Group type: EXPERIMENTAL
Intervention: 40 minutes of additional outdoor activities added to each school day.
Number of subjects: 1903
Study: 24239838

Group type: EXPERIMENTAL
Intervention: Lactococcus lactis JCM5805 yogurt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo yogurt
Number of subjects: 0
Study: 20861820

Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Doxercalciferol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevelamer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calcitriol and Doxercalciferol
Number of subjects: 60
Study: 18804486

Group type: EXPERIMENTAL
Intervention: Upright faces in frontal view
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inverted faces in frontal view
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Upright faces varied in viewpoint (rotated 45 degrees)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inverted faces varied in viewpoint (rotated 45 degrees)
Number of subjects: 16
Study: 16971821

Group type: COMPARATOR
Intervention: 12-week outpatient treatment
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: PTSD treatment
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Hyperarousal PTSD symptoms improvement
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Temporal course of symptom improvement
Number of subjects: 94
Study: 14594917

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment (CBT) programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study: 16143575

Group type: EXPERIMENTAL
Intervention: Sitting position (Group 1, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supine position (Group 2, n=20)
Number of subjects: 40
Study: 10511327

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (24 mg of beta-carotene, 1000 mg of ascorbate, and 800 IU of alpha-tocopherol daily for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (baseline and post-treatment phases)
Number of subjects: 40
Study: 7865226

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg and 600 mg)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum (1 mg and 7 mg)
Number of subjects: 41
Study: 2030255

Group type: EXPERIMENTAL
Intervention: LACTOSE
Number of subjects: 16

Group type: COMPARATOR
Intervention: NOCHO
Number of subjects: 16

Group type: COMPARATOR
Intervention: SUGAR
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 16

Group type: COMPARATOR
Intervention: Lactase-treated skim milk
Number of subjects: 16
Study: 7286357

Group type: EXPERIMENTAL
Intervention: Clofazimine 100 mg daily with sun exposure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clofazimine 100 mg daily without sun exposure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 27292774

Group type: EXPERIMENTAL
Intervention: Amoxicillin (AMX) at 10 mg/kg body weight (b.w.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amoxicillin (AMX) at 20 mg/kg body weight (b.w.)
Number of subjects: 0
Study: 26020589

Group type: EXPERIMENTAL
Intervention: Integration training (multisensory stimuli binding with tinnitus)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Attention diversion training (multisensory stimuli opposite side to tinnitus)
Number of subjects: 18
Study: 23879519

Group type: EXPERIMENTAL
Intervention: Psoriasis group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 30
Study: 22497062

Group type: EXPERIMENTAL
Intervention: SmokeCheck training program
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 165
Study: 19608812

Group type: EXPERIMENTAL
Intervention: Fosaprepitant 200 mg IV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg per os
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17512226

Group type: EXPERIMENTAL
Intervention: PTFE patch insertion
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Redo saphenofemoral ligation and great saphenous vein stripping with PTFE patch
Number of subjects: 31

Group type: COMPARATOR
Intervention: Redo saphenofemoral ligation and great saphenous vein stripping without PTFE patch
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups (with and without PTFE patch)
Number of subjects: 31
Study: 15180622

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 2102

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2102
Study: 11678394

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacemaker with rate drop response algorithm programmed to ON
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dual-chamber pacemaker programmed to OFF
Number of subjects: 50
Study: 9510488

Group type: EXPERIMENTAL
Intervention: Normal left ventricular systolic function (group A)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Left ventricular systolic dysfunction (group B)
Number of subjects: 240
Study: 7802219

Group type: EXPERIMENTAL
Intervention: Single medial injection using prilocaine 3% with felypressin
Number of subjects: 107

Group type: COMPARATOR
Intervention: Two injections using prilocaine 3% with felypressin
Number of subjects: 107
Study: 3293874

Group type: EXPERIMENTAL
Intervention: 100 mg/day carprofen
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 300 mg/day carprofen
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 600 mg/day carprofen
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 800 mg/day carprofen
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Carprofen concentrations greater than 10 micrograms/ml
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Carprofen concentrations below 1.9 micrograms/ml
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Carprofen (various doses)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Carprofen (up to 600 mg daily)
Number of subjects: 38
Study: 31992356

Group type: EXPERIMENTAL
Intervention: Mindfulness-enhanced version of the Strengthening Families Program (SFP-Mind)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Standard Strengthening Families Program 10-14 (SFP 10-14)
Number of subjects: 216
Study: 31622139

Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 11100

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 11100

Group type: EXPERIMENTAL
Intervention: Warning Label
Number of subjects: 11100

Group type: EXPERIMENTAL
Intervention: Health Star Rating (HSR)
Number of subjects: 11100

Group type: EXPERIMENTAL
Intervention: Reference Intakes
Number of subjects: 11100
Study: 27590364

Group type: EXPERIMENTAL
Intervention: CM-enhanced cognitive remediation training (CR-CM; n=19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard cognitive remediation training (CR-S; n=21)
Number of subjects: 40
Study: 25881455

Group type: EXPERIMENTAL
Intervention: Chuanhuang No.1 Recipe (CHR), 400 mL each time, one dose per day for 24 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Losartan Potassium, 50-100 mg per day for 24 weeks
Number of subjects: 60
Study: 23769179

Group type: EXPERIMENTAL
Intervention: Olmesartan (5.0-10mg initiated, increased up to 40mg/day)
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Control group (no ARBs allowed)
Number of subjects: 1147
Study: 21821220

Group type: EXPERIMENTAL
Intervention: Practice with an instructional video (group A)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Practice with supervision by an expert instructor (group B)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Independent practice (group C)
Number of subjects: 58
Study: 19820916

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation (ACI)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Microfracture
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Both ACI and Microfracture
Number of subjects: 67
Study: 17213238

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BT‐A) 500 units injected into the pectoralis major and biceps brachii on the hemiplegic side
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 15656877

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11871364

Group type: EXPERIMENTAL
Intervention: Short-acting beta2-agonist (salbutamol, n=41)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Long-acting beta2-agonist (formoterol, n=46)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (n=41)
Number of subjects: 128
Study: 9697913

Group type: COMPARATOR
Intervention: Group A (no drain)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group B (drain)
Number of subjects: 200
Study: 7530507

Group type: EXPERIMENTAL
Intervention: High serum levels of immunoreactive IL-6
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: High serum levels of C-reactive protein (CRP)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: High serum levels of alpha 1-antitrypsin (alpha 1AT)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: High serum levels of acid alpha 1-glycoprotein (orosomucoid; OM)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: High serum levels of beta 2-microglobulin (beta 2M)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: High serum levels of thymidine kinase
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Patients with high levels of both beta 2M and alpha 1AT or IL-6
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Normal vs raised serum IL-6 levels
Number of subjects: 210
Study: 2131924

Group type: EXPERIMENTAL
Intervention: clebopride
Number of subjects: 30

Group type: COMPARATOR
Intervention: domperidone
Number of subjects: 30
Study: 419955

Group type: EXPERIMENTAL
Intervention: Paracervical block (PCB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 31255302

Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI); n=12
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sleep Monitoring (SM); n=11
Number of subjects: 23
Study: 28052790

Group type: EXPERIMENTAL
Intervention: Patient hand-hygiene intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 24621065

Group type: EXPERIMENTAL
Intervention: 30 mg zinc daily for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo daily for 12 weeks
Number of subjects: 50
Study: 23909679

Group type: EXPERIMENTAL
Intervention: Oral propranolol treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 22

Group type: COMPARATOR
Intervention: Patients with venous malformations
Number of subjects: 22
Study: 21792626

Group type: EXPERIMENTAL
Intervention: Anastrozole, Fulvestrant, and Gefitinib (AFG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Anastrozole and Fulvestrant
Number of subjects: 15
Study: 19781069

Group type: EXPERIMENTAL
Intervention: Transinguinal preperitoneal technique with soft mesh
Number of subjects: 300

Group type: COMPARATOR
Intervention: Lichtenstein technique
Number of subjects: 300
Study: 16733158

Group type: EXPERIMENTAL
Intervention: Off-pump coronary surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional coronary surgery
Number of subjects: 50
Study: 15223416

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thoracic sympathectomy (TS)
Number of subjects: 20
Study: 11359594

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with intravenous propofol sedation (SA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inhalational sevoflurane anaesthesia (IA)
Number of subjects: 40
Study: 9304087

Group type: EXPERIMENTAL
Intervention: 2% clindamycin vaginal cream (100 mg/day for 7 days)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Oral amoxicillin (2 g/day for 7 days)
Number of subjects: 105
Study: 8389108

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 1,000 micrograms/day for 2 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3625417

Group type: EXPERIMENTAL
Intervention: Human milk with mineral supplementation (high mineral formula)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Human milk with powdered fortifier
Number of subjects: 50

Group type: COMPARATOR
Intervention: Unsupplemented human milk
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups at follow-up (44 weeks postconceptional age)
Number of subjects: 50
Study: 31932387

Group type: EXPERIMENTAL
Intervention: Simple dressing
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Glue-as-a-dressing
Number of subjects: 394

Group type: COMPARATOR
Intervention: No dressing
Number of subjects: 394
Study: 29108797

Group type: EXPERIMENTAL
Intervention: Protease inhibitor plus NRTI group (lopinavir 400 mg with ritonavir 100 mg, twice per day plus two or three clinician-selected NRTIs)
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Protease inhibitor plus raltegravir group (lopinavir plus raltegravir 400 mg twice per day)
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Protease inhibitor monotherapy group (lopinavir monotherapy plus raltegravir induction for first 12 weeks, re-intensified to combination therapy after week 96)
Number of subjects: 1277
Study: 27322832

Group type: EXPERIMENTAL
Intervention: Video with information about the benefits of organ donation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Video without information about the benefits of organ donation
Number of subjects: 0
Study: 25357218

Group type: EXPERIMENTAL
Intervention: Osteopathy (3 sessions at 15, 30, and 45 days after infliximab infusion)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (simple follow-up)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Osteopathy
Number of subjects: 38
Study: 22838004

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Task (PASAT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (HS alone)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CPT
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: PASAT
Number of subjects: 14
Study: 20415897

Group type: EXPERIMENTAL
Intervention: Belatacept (more intensive regimen)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belatacept (less intensive regimen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 0
Study: 18375318

Group type: EXPERIMENTAL
Intervention: ACE‐Is (ramipril, 1.25 mg twice a day from the day after the operation)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no ACE‐Is)
Number of subjects: 34
Study: 15262194

Group type: EXPERIMENTAL
Intervention: d‐alpha‐tocopherol 750 IU (group AE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Atorvastatin 20mg with placebo (group AP)
Number of subjects: 22